| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16634
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-58 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2017-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2022-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-102457556-B1 |
| titleOfInvention |
Means and methods for the treatment of HSV |
| abstract |
The present invention relates to a vaccine composition comprising a multimeric complex of a Herpes Simplex Virus (HSV) polypeptide for treatment or vaccination against HSV. The present invention also relates to vectors comprising polynucleotides encoding HSV polypeptides and to host cells comprising said vectors. The present invention further includes a method for producing a vaccine composition. |
| priorityDate |
2016-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |